Editorial
Expression level of GRP78/BiP as a predictor of favorable or unfavorable outcomes in cancer patients
Abstract
The article “High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma” recently published in the International Journal of Clinical Oncology describes GRP78/BiP as a marker of favorable outcomes in a particular cancer: advanced thymic carcinoma, a statement a priori in opposition to most of the results published on this topic.
